Precompetitive collaboration on enabling technologies for the pharmaceutical industry

Organic Process Research and Development

Volumn 18, Issue 4, 2014, Pages 481-487

  Welch, Christopher J ^a   Hawkins, Joel M ^b   Tom, Jean ^c  

^a MERCK RESEARCH LABORATORIES   (United States)

^b PFIZER INC   (United States)

^c BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMISTRY;

CHEMICAL RESEARCH; COLLABORATIVE DEVELOPMENT; ENABLING TECHNOLOGIES; INTELLECTUAL INPUT; MULTIPARTY COLLABORATIONS; PENNSYLVANIA; PHARMACEUTICAL INDUSTRY; STREAMLINE OPERATIONS;

INDUSTRY;

EID: 84899019500     PISSN: 10836160     EISSN: 1520586X     Source Type: Journal    
DOI: 10.1021/op500023q     Document Type: Article

References (11)

1. Pain, E., Science Careers, Dec 9, 2011, 10.1126/science.caredit.a1100136.
2. Munos, B. Nat. Rev. Drug Discovery 2009, 8, 959
3. Pammolli, F.; Magazzini, L.; Riccaboni, M. Nat. Rev. Drug Discovery 2011, 10, 428
4. Although recent increases in New Molecular Entity approvals are noted from 2011 to 2013 Mullard, A. Nat. Rev. Drug Discovery 2014, 13, 85
5. June 12-13, 2013, http://www.ccrhq.org/collaborate/events/precompetitive- collaborations
6. Hawkins, J. M.; Watson, T. J. N. Angew. Chem. 2004, 43, 3224
7. http://ec.europa.eu/programmes/horizon2020/.
8. Goldman, M. Clin. Pharm. Ther. 2012, 91 (3) 418
9. It should be noted that many of the technology goals of pharma align well with the NSFs goals for sustainability, see: The National Science Foundations Investment in Sustainable Chemistry, Engineering, and Materials White, A. A.; Platz, M. S.; Aruguete, D. M.; Jones, S. L.; Madsen, L. D.; Wesson, R. D. ACS Sustainable Chem. Eng. 2013, 1 (8) 871-877
10. Lauber, M. B.; Stahl, S. S. ACS Catal. 2013, 3 (11) 2612
11. Greene, J. F.; Hoover, J. M.; Mannel, D. S.; Root, T. W.; Stahl, S. S. Org. Process Res. Dev 2013, 17 (10) 1247